Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FlowSense has received FDA breakthrough designation and has published clinical data in Science and Nature family journals. The device enables rapid, noninvasive detection of CSF flow in hydrocephalus shunts at the bedside or point-of-care. Initial hospital launch planned with pipeline expansion to at-home use. Over $19M raised to date from dilutive and non-dilutive sources including NIH/NSF grants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhaeos.